approval · primary record
DATOPOTAMAB DERUXTECAN-DLNK
FDA · BLA · 2025-06-23
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-06-23 |
| Brand | DATROWAY |
| Sponsor | DAIICHI SANKYO INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:39:27.116Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DATOPOTAMAB DERUXTECAN-DLNK:2025-06-23
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Datopotamab Deruxtecan-Dlnk · compound